Angiotensin converting enzyme (ACE) inhibitors are extensively used for the prevention and treatment of cardiovascular diseases with a wide range of clinical recommendations. The use of ACE inhibitors can cause the onset of a dry cough, whose prevalence has probably been overestimated because of the lack of adequate control. A correct interpretation of available data requires a careful evaluation of placebo-controlled studies to definitely assess the rate of the most frequent adverse event of ACE inhibition.
Borghi, C., Veronesi, M. (2019). Cough and ACE Inhibitors: The Truth Beyond Placebo. CLINICAL PHARMACOLOGY & THERAPEUTICS, 105(3), 550-552 [10.1002/cpt.1040].
Cough and ACE Inhibitors: The Truth Beyond Placebo.
Borghi, Claudio
Primo
Writing – Original Draft Preparation
;Veronesi, MaddalenaSecondo
Writing – Review & Editing
2019
Abstract
Angiotensin converting enzyme (ACE) inhibitors are extensively used for the prevention and treatment of cardiovascular diseases with a wide range of clinical recommendations. The use of ACE inhibitors can cause the onset of a dry cough, whose prevalence has probably been overestimated because of the lack of adequate control. A correct interpretation of available data requires a careful evaluation of placebo-controlled studies to definitely assess the rate of the most frequent adverse event of ACE inhibition.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
